Clinical Trials Directory

Trials / Unknown

UnknownNCT02061150

Neonatal Sepsis Workup for High Risk Newborns - Evaluation of Need and Ways to Prevent

Status
Unknown
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
48 Hours
Healthy volunteers
Not accepted

Summary

Sepsis is a significant cause of morbidity and mortality among newborns. Due to strict criteria and in order to diagnose and prevent early-onset group B streptococcal (EOGBS) sepsis, many infants undergo a sepsis workup due to risk factors alone, even though they are asymptomatic. Our goal is to evaluate the number of newborns that undergo sepsis workup due to risk factors alone, to determine the number of newborns having positive blood cultures, and to establish ways to reduce the number of asymptomatic infants undergoing sepsis workup.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2015-02-01
Completion
2015-06-01
First posted
2014-02-12
Last updated
2014-02-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02061150. Inclusion in this directory is not an endorsement.